RYDAPT Trademark

Trademark Overview

On Friday, August 31, 2007, a trademark application was filed for RYDAPT with the United States Patent and Trademark Office. The USPTO has given the RYDAPT trademark a serial number of 79043585. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 9, 2015. This trademark is owned by NOVARTIS AG. The RYDAPT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the genitourinary system, for musculo-skeletal and inflammatory disorders, and for use in dermatology, oncology, hematology, ophthalmology, and in tissue and organ transplantation, and for the treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of gastroenterological disorders, and for the prevention and treatment of ocular disorders; Pharmaceutical products, namely, anti-infective preparations, antibiotics, antibacterial substances for medical purposes, antiviral preparations, antifungal preparations, and vaccines
rydapt

General Information

Serial Number79043585
Word MarkRYDAPT
Filing DateFriday, August 31, 2007
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 9, 2015
Registration Number3441082
Registration DateTuesday, June 3, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the genitourinary system, for musculo-skeletal and inflammatory disorders, and for use in dermatology, oncology, hematology, ophthalmology, and in tissue and organ transplantation, and for the treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of gastroenterological disorders, and for the prevention and treatment of ocular disorders; Pharmaceutical products, namely, anti-infective preparations, antibiotics, antibacterial substances for medical purposes, antiviral preparations, antifungal preparations, and vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 9, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Thursday, September 14, 2017INTERNATIONAL REGISTRATION RENEWED
Friday, October 16, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, September 24, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, September 24, 2015INVALIDATION PROCESSED
Wednesday, September 9, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 6, 2015NOTIFICATION PROCESSED BY IB
Friday, January 9, 2015CANCELLED SECTION 71
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 7, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 19, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 22, 2008FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 22, 2008FINAL DISPOSITION PROCESSED
Thursday, September 4, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 3, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2008NOTICE OF PUBLICATION
Monday, February 11, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 11, 2008ASSIGNED TO LIE
Tuesday, January 8, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 8, 2008EXAMINER'S AMENDMENT ENTERED
Tuesday, January 8, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 8, 2008EXAMINERS AMENDMENT E-MAILED
Tuesday, January 8, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, January 3, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 3, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 4, 2008REFUSAL PROCESSED BY IB
Friday, December 14, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 14, 2007REFUSAL PROCESSED BY MPU
Friday, December 14, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 13, 2007NON-FINAL ACTION WRITTEN
Saturday, December 8, 2007ASSIGNED TO EXAMINER
Friday, October 12, 2007NEW APPLICATION ENTERED IN TRAM
Friday, October 12, 2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, October 11, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

rydapt system preparations treatment disorders prevention pharmaceutical anti products namely gastroenterological